Healthcare earnings calendar for the week of February 6th
Sunday, 5-February-2017
All conference call times Eastern. - Special thanks to @TomMathies for helping me compile this list. Very nice of him to take the time to do that.
Monday, February 6
Arrowhead Pharmaceuticals (ARWR) - 4:30 PM
Catalent, Inc. (CTLT) - 4:45 PM
Haemonetics (HAE) - 8:00 AM
IRadimed (IRMD) - 11:00 AM
Kamada (KMDA) - 8:30 AM
Luminex (LMNX) - 4:30 PM
Tuesday, February 7
Bio-Techne (TECH) - 9:00 AM
Cardinal Health (CAH) - 8:30 AM
Centene Corporation (CNC) - 8:30 AM
Cynosure (CYNO) - 9:00 AM
Dextera Surgical (DXTR) - 4:30 PM
Gilead Sciences (GILD) - 4:30 PM
GW PHarmaceuticals (GWPH) - 8:30 AM
Mallinckrodt (MNK) - 8:30 AM
MEDNAX (MD) - 10:00 AM
Myraid Genetics (MYGN) - 4:30 PM
- Hereditary Cancer Testing Revenue
PharmaCyte Biotech shareholder call (PMCB) - 4:30 PM
Phibro Animal Health Corporation (PAHC) - 9:00 AM
pSivida Corp. (PSDV) - 4:30 PM
Quotient Limited (QTNT) - 8:30 AM
STERIS plc (STE) - 10:00 AM
WellCare (WCG) - 9:30 AM
Wednesday, February 8
Allergan (AGN) - 8:30 AM
Alnylam (ALNY) - 4:30 PM
Applied Genetic Technologies Corporation (AGTC) - 4:30 PM
Electromed, Inc. (ELMD) - 9:00 AM
Enanta Pharmaceuticals (ENTA) - 4:30 PM
Fluidigm (FLDM) - 5:00 PM
GlaxoSmithKline (GSK) - 9:30 AM
OraSure TEchnologies (OSUR) - 5:00 PM
Quidel (QDEL) - 5:00 PM
Sanofi (SNY) - 8:00 AM
Thursday, February 9
Array BioPharma (ARRY) - 9:00 AM
Aytu BioScience (AYTU) - 4:30 PM
Cerner (CERN) - 4:30 PM
Computer Programs & Systems, Inc. (CPSI) - 4:30 PM
CVS Health Corporation (CVS) - 8:30 AM
ImmuCell (ICCC) - 4:30 PM
Innoviva (INVA) - 5:00 PM
NuVasive (NUVA) - 4:30 PM
Organovo (ONVO) - 5:00 PM
Palatin Technologies (PTN) - 11:00 AM
Regeneron (REGN) - 8:30 AM
Seattle Genetics (SGEN) - 4:30 PM
Smith & Nephew (SNN) - 4:00 AM
Sonoma Pharmaceuticals (SNOA) - 4:30 PM
VCA, Inc. (WOOF) - 9:00 AM
Friday, February 10
Aethlon Medical (AEMD) - 4:30 PM
Please let me know if I omitted any names and I'll be happy to add.
Who Am I?
I'm an individual investor from Kansas City. My focus is on biotech stocks, but I enjoy investing in all industries. I'm an old-school, buy and hold investor who believes the best way to outperform and grow capital is to own innovative companies with good management teams over the long-term. more>>>